✦ LIBER ✦

Long-term outcome in relapsed and refractory multiple myeloma treated with thalidomide. Balancing efficacy and side-effects

✍ Scribed by Alessandro Corso; Patrizia Zappasodi; Luciana Barbarano; Maria Teresa Petrucci; Antonio Palumbo; Tommaso Caravita; Silvia Mangiacavalli; Anna Maria Cafro; Marzia Varettoni; Francesca Gay; Enrica Morra; Mario Lazzarino

Book ID: 104041026
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 474 KB
Volume: 33
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2009.03.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term results of thalidomide in refr

Long-term results of thalidomide in refractory and relapsed multiple myeloma with emphasis on response duration

✍ M. Teresa Cibeira; Laura Rosiñol; Laia Ramiro; Jordi Esteve; Montserrat Torrebad 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB

Impact on response and survival of DNA r

Impact on response and survival of DNA repair single nucleotide polymorphisms in relapsed or refractory multiple myeloma patients treated with thalidomide

✍ María Teresa Cibeira; Carlos Fernández de Larrea; Alfons Navarro; Tania Díaz; Do 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 332 KB

Efficacy of single-agent bortezomib vs.

Efficacy of single-agent bortezomib vs. single-agent thalidomide in patients with relapsed or refractory multiple myeloma: a systematic comparison

✍ H. Miles Prince; Michael Adena; Dell Kingsford Smith; Judy Hertel 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 593 KB

Thalidomide in consecutive multiple myel

Thalidomide in consecutive multiple myeloma patients: single-center analysis on practical aspects, efficacy, side effects and prognostic factors with lower thalidomide doses

✍ P. S. Haas; U. Denz; G. Ihorst; M. Engelhardt 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

Clinical efficacy of a bortezomib, cyclo

Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II study

✍ Yeo-Kyeoung Kim; Sang-Kyun Sohn; Jae-Hoon Lee; Deok-Hwan Yang; Joon-Ho Moon; Jae 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 175 KB

Allogeneic Hematopoietic Stem Cell Trans

Allogeneic Hematopoietic Stem Cell Transplantation With Reduced-Intensity Conditioning In Patients With Refractory And Relapsing Multiple Myeloma: Long-Term Follow-Up

✍ A. Shimoni; I. Hardan; F. Ayuk; G. Schilling; D. Atanackovic; W. Zeller; N. Shem 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 77 KB